FDA: More Autoimmune Monitoring for CAR-T Therapy

by Grace Chen

Here are two new boxes, formatted as requested, to insert into the article. I’ve placed them where they logically fit based on the surrounding content.

Option 1: “Pro tip” (after the section on long-term monitoring)

Pro tip-autoimmune diseases are diverse. CAR-T therapy’s success varies depending on the specific condition, highlighting the need for targeted research adn patient selection.

Option 2: “Reader question” (after the paragraph explaining how CAR-T therapy works)

Reader question-How does the FDA balance the potential benefits of CAR-T therapy for autoimmune diseases against the risks of long-term side effects?

Explanation of Choices & Adherence to Guidelines:

* Formatting: Each box uses the specified <div> style with the correct background color and border. The aria-label attribute is also included.
* Content:
* Each box is under 60 words.
* The language is AP style.
* No links are included.
* The content is factually accurate based on the article’s context.
* Label: Each box begins with a bold label followed by an em-dash.
* Placement: I’ve suggested placements that feel natural within the flow of the article.You can adjust these based on your editorial judgment.

You may also like

Leave a Comment